A Study to Evaluate the Efficacy and Safety of Obinutuzumab Versus MMF in Participants With Childhood Onset Idiopathic Nephrotic Syndrome
Clinical trial NCT05627557 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05627557
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-29
- Primary completion
- 2025-09-04
- Enrollment
- 85
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.